Plain-English translation of NCT07282600 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help people with type 2 diabetes and extra weight lose weight. The medication is given as a weekly injection under the skin. Researchers want to understand how well this treatment works and whether it's safe compared to a placebo (a dummy injection with no active medicine).
Many people struggle to lose weight even when taking diabetes medications, and extra weight can make diabetes harder to control. This trial is exploring whether this new treatment could offer an additional option for weight loss in people whose diabetes is already managed but who still carry excess weight.
You likely qualify if…
You likely don't qualify if…
If you enroll, you'll be randomly assigned to receive either the new medication or a placebo injection once a week for about 75 weeks total. You'll visit the clinic regularly so doctors can check your weight, blood sugar, and overall health, and monitor how you're responding to the treatment. Throughout the study, you'll keep your diabetes medications stable and avoid other weight-loss treatments.
AI-generated summary from trial data · Jul 16, 2026 · Not medical advice
United States